ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 243 filers reported holding ARENA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $6,104,000 | +22.0% | 65,670 | -21.8% | 0.05% | +14.9% |
| Q3 2021 | $5,003,000 | -4.5% | 84,018 | +9.4% | 0.05% | -2.1% |
| Q2 2021 | $5,237,000 | +1.2% | 76,797 | +2.9% | 0.05% | -5.9% |
| Q1 2021 | $5,176,000 | +43.5% | 74,599 | +58.9% | 0.05% | +41.7% |
| Q4 2020 | $3,607,000 | +158.6% | 46,948 | +151.8% | 0.04% | +125.0% |
| Q3 2020 | $1,395,000 | +22.3% | 18,647 | +2.8% | 0.02% | +14.3% |
| Q2 2020 | $1,141,000 | +74.7% | 18,133 | +16.7% | 0.01% | +55.6% |
| Q1 2020 | $653,000 | -25.7% | 15,541 | -19.7% | 0.01% | -10.0% |
| Q4 2019 | $879,000 | -0.8% | 19,363 | 0.0% | 0.01% | -9.1% |
| Q3 2019 | $886,000 | -21.9% | 19,363 | 0.0% | 0.01% | -21.4% |
| Q2 2019 | $1,135,000 | +35.8% | 19,363 | +3.8% | 0.01% | +40.0% |
| Q1 2019 | $836,000 | +15.2% | 18,649 | 0.0% | 0.01% | 0.0% |
| Q4 2018 | $726,000 | -8.8% | 18,649 | +7.8% | 0.01% | 0.0% |
| Q3 2018 | $796,000 | -2.0% | 17,297 | -7.1% | 0.01% | 0.0% |
| Q2 2018 | $812,000 | +10.5% | 18,619 | 0.0% | 0.01% | +11.1% |
| Q1 2018 | $735,000 | – | 18,619 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 163,133 | $7,467,000 | 4.14% |
| PFM Health Sciences, LP | 2,271,536 | $103,968,000 | 3.07% |
| Partner Investment Management, L.P. | 28,877 | $1,322,000 | 2.26% |
| Atika Capital Management LLC | 181,000 | $8,284,000 | 1.74% |
| DAFNA Capital Management LLC | 93,942 | $4,300,000 | 1.62% |
| Asymmetry Capital Management, L.P. | 16,272 | $745,000 | 1.60% |
| First Light Asset Management, LLC | 190,838 | $8,735,000 | 1.32% |
| Perceptive Advisors | 953,129 | $43,624,000 | 1.18% |
| Rhenman & Partners Asset Management AB | 155,000 | $7,094,000 | 0.89% |
| Opus Point Partners Management, LLC | 9,770 | $447,000 | 0.81% |